Tag-Free Tetanus Toxin Purification With Chelate and Anion Exchange

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for purifying tetanus toxin and its variants are inefficient, with low product yield and high production costs, making them unsuitable for industrial-scale production.

Innovation Solution

The use of biocompatible agarose-based nickel affinity chromatography and anion exchange chromatography for purifying tetanus toxin and its variants without affinity tags, allowing for rapid isolation with high purity and recovery rate.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Manufacturing precision

If multi-step chromatography purification is used for tetanus toxin fragment C, then the purity of the target protein can reach 95-96.7%, but the purification process becomes complex and the product yield decreases

Engineering Contradiction:
ImprovepurityVSAvoidpurification process complexity
Core Design Contradiction:
Manufacturing precisionVSDevice complexity

Solution Approach 1:

The patent segments the complex multi-step purification process into distinct functional modules: affinity chromatography for initial capture, ion exchange chromatography for intermediate purification, and gel filtration for final polishing. Each module targets specific impurity types, achieving 95-96.7% purity through coordinated action of simplified sequential steps rather than a single complex process.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent introduces affinity tags (such as His-tag) as intermediary elements that temporarily attach to the target protein during purification. These tags mediate specific binding to affinity chromatography media, enabling selective capture of the target protein while leaving impurities behind. The tags are later removed to yield the pure native protein, thus facilitating purification without requiring complex direct separation methods.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Manufacturing precision

If multi-step chromatography purification is used for tetanus toxin fragment C, then the purity of the target protein can reach 95-96.7%, but the production cost increases

Engineering Contradiction:
ImprovepurityVSAvoidproduction cost
Core Design Contradiction:
Manufacturing precisionVSEase of manufacture

Solution Approach 1:

The patent incorporates affinity tags into the target protein during the expression stage, performing the purification facilitation action beforehand. This preliminary modification enables the protein to be captured directly by affinity chromatography media in the first purification step, eliminating the need for multiple complex separation steps and reducing overall production costs while maintaining high purity.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent optimizes purification parameters at each stage: selecting appropriate pH and salt concentrations for ion exchange chromatography, choosing suitable elution conditions for affinity chromatography, and adjusting flow rates and column dimensions for gel filtration. These parameter optimizations maximize purification efficiency at each step, reducing material waste and operational costs while achieving the required 95-96.7% purity.

Inventive Principle:
Principle #35Parameter changes

3Reliability

If conventional purification methods are used for tetanus toxin, then the purification can be achieved, but the productivity is low and unsuitable for industrial-scale production

Engineering Contradiction:
Improvepurification effectivenessVSAvoidproduction efficiency
Core Design Contradiction:
ReliabilityVSProductivity

Solution Approach 1:

The patent extracts and removes common impurities at specific stages: using affinity chromatography to extract and remove non-target proteins in the first step, employing ion exchange chromatography to extract nucleic acids and endotoxins in the second step, and using gel filtration to extract remaining aggregates in the final step. This systematic extraction approach ensures high purity while maintaining high productivity suitable for industrial production.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent employs a composite purification strategy combining three different chromatography technologies with complementary mechanisms: affinity chromatography (specific biological recognition), ion exchange chromatography (electrostatic interaction), and gel filtration (size-based separation). This composite approach leverages the strengths of each method to achieve comprehensive purification in a streamlined process that is both reliable and highly productive for industrial-scale tetanus toxin production.

Inventive Principle:
Principle #40Composite materials

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This method significantly improves the separation and purification efficiency of tetanus toxin and its variants, reducing production costs and facilitating large-scale production.

Implementation Method 1

Its principle is to use multiple amino acids (e.g., histidine) on the protein surface to undergo special coordination binding with transition metal ions (e.g., Ni2+, Cu2+, Zn2+, Co2+, etc.), thereby achieving specific purification and separation

Methodology Applied
Scientific EffectCoordination binding: Chemical Bonding

Implementation Method 2

a two-step purification using ion exchange and gel filtration chromatography

Methodology Applied
Scientific EffectIon exchange: Ion Exchange

Data Source

PatentUS20250290058A1Method for purifying tetanus toxin or variants thereof
Publication Date: 2025.09.18 SHANGHAI RUIZHOU BIOTECH CO LTD
  • US20250290058A1 patent drawing
  • US20250290058A1 patent drawing
  • US20250290058A1 patent drawing

AI summary

The present disclosure discloses a method for purifying tetanus toxin or variants thereof. The method for purifying tetanus toxin or variants thereof uses metal chelate affinity chromatography, and the tetanus toxin does not contain an affinity tag. The present disclosure uses biocompatible agarose-based nickel affinity chromatography and anion exchange chromatography as separation subjects, which can quickly and effectively remove impure proteins and enrich target proteins; it improves the separation and purification efficiency of proteins and greatly reduces the loss of proteins.